Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

This study has been completed.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by:
Seattle Genetics, Inc.
ClinicalTrials.gov Identifier:
NCT00079716
First received: March 11, 2004
Last updated: June 7, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)